THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 83 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $125,000 | +66.7% | 197,207 | +25.6% | 0.00% | – |
| Q4 2015 | $75,000 | -95.0% | 157,001 | -57.0% | 0.00% | -100.0% |
| Q3 2015 | $1,488,000 | -5.3% | 365,498 | -6.0% | 0.00% | 0.0% |
| Q2 2015 | $1,572,000 | +5.9% | 388,905 | +6.3% | 0.00% | +100.0% |
| Q1 2015 | $1,485,000 | +5.0% | 365,882 | -17.7% | 0.00% | 0.0% |
| Q4 2014 | $1,414,000 | -5.2% | 444,474 | +7.6% | 0.00% | 0.0% |
| Q3 2014 | $1,491,000 | +50.3% | 413,043 | +64.9% | 0.00% | 0.0% |
| Q2 2014 | $992,000 | -21.3% | 250,494 | -5.4% | 0.00% | 0.0% |
| Q1 2014 | $1,260,000 | +21.5% | 264,808 | +19.2% | 0.00% | 0.0% |
| Q4 2013 | $1,037,000 | +19.5% | 222,109 | +19.0% | 0.00% | 0.0% |
| Q3 2013 | $868,000 | -28.2% | 186,648 | -18.8% | 0.00% | 0.0% |
| Q2 2013 | $1,209,000 | +59.1% | 229,743 | +39.3% | 0.00% | 0.0% |
| Q1 2013 | $760,000 | – | 164,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CG Asset Management LLC | 207,000 | $842,000 | 0.36% |
| GREAT POINT PARTNERS LLC | 210,800 | $858,000 | 0.34% |
| TFS CAPITAL LLC | 773,262 | $3,147,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 201,537 | $820,000 | 0.13% |
| FORTALEZA ASSET MANAGEMENT INC/ | 42,010 | $171,000 | 0.12% |
| Baker Brothers Advisors | 2,925,519 | $11,907,000 | 0.11% |
| OXFORD ASSET MANAGEMENT LLP | 591,180 | $2,406,000 | 0.08% |
| FRANKLIN STREET ADVISORS INC /NC | 70,000 | $285,000 | 0.06% |
| FEDERATED HERMES, INC. | 3,926,865 | $15,982,000 | 0.05% |
| Nine Chapters Capital Management LLC | 136,811 | $557,000 | 0.05% |